• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Pathog . SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infec

tetano

Editor, Senior Moderator
PLoS Pathog


. 2020 Sep 18;16(9):e1008903.
doi: 10.1371/journal.ppat.1008903. Online ahead of print.
SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts


Amy L Hartman[SUP] 1 2 [/SUP], Sham Nambulli[SUP] 1 3 [/SUP], Cynthia M McMillen[SUP] 1 2 [/SUP], Alexander G White[SUP] 3 [/SUP], Natasha L Tilston-Lunel[SUP] 1 3 [/SUP], Joseph R Albe[SUP] 1 [/SUP], Emily Cottle[SUP] 1 [/SUP], Matthew D Dunn[SUP] 1 [/SUP], L James Frye[SUP] 3 [/SUP], Theron H Gilliland[SUP] 1 [/SUP], Emily L Olsen[SUP] 1 [/SUP], Katherine J O'Malley[SUP] 1 [/SUP], Madeline M Schwarz[SUP] 1 2 [/SUP], Jaime A Tomko[SUP] 3 [/SUP], Reagan C Walker[SUP] 4 [/SUP], Mengying Xia[SUP] 1 [/SUP], Matthew S Hartman[SUP] 5 [/SUP], Edwin Klein[SUP] 4 [/SUP], Charles A Scanga[SUP] 1 3 [/SUP], JoAnne L Flynn[SUP] 1 3 [/SUP], William B Klimstra[SUP] 1 6 [/SUP], Anita K McElroy[SUP] 1 7 [/SUP], Douglas S Reed[SUP] 1 6 [/SUP], W Paul Duprex[SUP] 1 3 [/SUP]



Affiliations

Abstract

Vaccines are urgently needed to combat the global coronavirus disease 2019 (COVID-19) pandemic, and testing of candidate vaccines in an appropriate non-human primate (NHP) model is a critical step in the process. Infection of African green monkeys (AGM) with a low passage human isolate of SARS-CoV-2 by aerosol or mucosal exposure resulted in mild clinical infection with a transient decrease in lung tidal volume. Imaging with human clinical-grade 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) co-registered with computed tomography (CT) revealed pulmonary lesions at 4 days post-infection (dpi) that resolved over time. Infectious virus was shed from both respiratory and gastrointestinal (GI) tracts in all animals in a biphasic manner, first between 2-7 dpi followed by a recrudescence at 14-21 dpi. Viral RNA (vRNA) was found throughout both respiratory and gastrointestinal systems at necropsy with higher levels of vRNA found within the GI tract tissues. All animals seroconverted simultaneously for IgM and IgG, which has also been documented in human COVID-19 cases. Young AGM represent an species to study mild/subclinical COVID-19 disease and with possible insights into live virus shedding. Future vaccine evaluation can be performed in AGM with correlates of efficacy being lung lesions by PET/CT, virus shedding, and tissue viral load.
 
Back
Top Bottom